 SHANGHAI, Mar. 17, 2021 PRNewswire -- Zhongchao Inc. NASDAQ: ZCMD Zhongchao or the Company, a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced the renewal of its partnership with the China Association for Health Promotion and Education and GlaxoSmithKline China Investment Limited to continue the medical education program Pulmonary Arterial Hypertension Online Course Connections with Famous Hospitals PAH Project in 2021. The PAH Project aims to promote the implementation of the multidisciplinary treatment model of pulmonary hypertension and improve doctors ability to solve clinical problems. 